METHOD OF MAKING AN OSTEOCONDUCTIVE FIBROUS ARTICLE AND A MEDICAL IMPLANT COMPRISING SUCH OSTEOCONDUCTIVE FIBROUS ARTICLE
The disclosure relates to a method of making a bioactive coating on a fibrous article for use in a medical implant and implants comprising non-biodegradable fibers, a coating polymer layer formed from a non-biodegradable coating polymer on at least a portion of the fibers, and a bioactive coating disposed on at least a portion of the polymer coating layer. In an embodiment, a method of forming a medical implant results in bioactive ceramic particles being partly embedded in the coating polymer layer.
1 . An implant comprising:
a) fibers comprising a non-biodegradable fiber polymer;
b) a polymer coating disposed on at least a portion of the fibers, the polymer coating comprising a non-biodegradable coating polymer, a polymer coating outer surface, a polymer coating thickness, and a polymer coating mass, wherein the polymer coating mass is from 0.1 to 3 mass % of the total mass of the fibers and the polymer coating together; and
c) a bioactive coating disposed on at least a portion of the polymer coating and defining a plurality of non-uniform first regions and a plurality of non-uniform second regions, the bioactive coating comprising a plurality of bioactive ceramic particles having a d50 particle size of 0.1-10 μm, as measured with light diffraction according to ISO 13320:2009, and a bioactive coating mass, wherein the bioactive coating mass is from 0.1 to 20 mass % of the total mass of the implant;
wherein the plurality of non-uniform first regions comprise a portion of the polymer coating outer surface exposed at an outer surface of the implant and the plurality of non-uniform second regions comprise a portion of the plurality of bioactive ceramic particles exposed above the polymer coating outer surface, and
wherein the plurality of non-uniform first regions and the plurality of non-uniform second regions are interspersed among one another.
2 . The implant according to claim 1 , wherein the non-biodegradable fiber polymer comprises polyethylene terephthalate (PET).
3 . The implant according to claim 1 , wherein the non-biodegradable fiber polymer comprises ultra-high molar mass polyethylene (UHMWPE).
4 . The implant according to claim 1 , wherein the fibers consist of the non-biodegradable fiber polymer.
5 . The implant according to claim 1 , wherein at least a portion of the plurality of bioactive ceramic particles extend below the polymer coating outer surface.
6 . The implant according to claim 1 , wherein the d50 particle size of the plurality of bioactive ceramic particles, as measured with light diffraction according to ISO 133202009, is greater than the polymer coating thickness.
7 . The implant according to claim 1 , wherein the bioactive ceramic particles have a d50 particle size of 0.1-6 μm, as measured with light diffraction according to ISO 13320-2009.
8 . The implant according to claim 1 , wherein the bioactive coating mass is greater than the polymer coating mass.
9 . The implant according to claim 1 , wherein the bioactive coating mass is from 0.5 mass % to 10 mass %, based on the total mass of the implant.
10 . The implant according to claim 1 , wherein the bioactive coating mass is from 0.1 mass % to 5 mass %, based on the total mass of the implant.
11 . The implant according to claim 1 , wherein non-biodegradable coating polymer comprises a copolyester or a polyurethane.
12 . The implant according to claim 1 , wherein the non-biodegradable coating polymer is a thermoplastic elastomer and a polyurethane block copolymer comprising a hard block and a soft block, the soft block being formed from an aliphatic polyester diol, an aliphatic polyether diol, and/or a polysiloxane diol.
13 . The implant according to claim 12 , wherein the polyurethane block copolymer comprises a hard block and a soft block and the soft block comprises an aliphatic polycarbonate.
14 . The implant according to claim 1 , wherein the non-biodegradable coating polymer is swellable or softenable in tetrahydrofuran (THF), methyl-tetrahydrofuran (m-THF), dimethylformamide (DMF), dimethylacetamide (DMAc), dimethylsulfoxide (DMSO), dioxane, dioxolane, or mixtures thereof and is not swellable or softenable in either ethanol or water.
15 . The implant according to claim 1 , wherein the non-biodegradable coating polymer has a durometer hardness as measured with the Shore test of from 60 ShA to 80 ShD.
16 . The implant according to claim 1 , wherein the bioactive ceramic particles comprise calcium phosphate particles or bioactive glass particles.
17 . The implant according to claim 1 , wherein the non-biodegradable coating polymer does not comprise a chemical modification at the polymer coating outer surface.
18 . The implant according to claim 1 , wherein the non-biodegradable coating polymer has a molar mass at the polymer coating outer surface that is not less than the molar mass of the non-biodegradable coating polymer elsewhere within the polymer coating.
19 . The implant according to claim 1 , wherein the polymer coating thickness is from 0.05 to 50 μm.
20 . The implant according to claim 1 , wherein the polymer coating thickness is from 0.05 to 20 μm.
21 . The implant according to claim 1 , wherein the fibers are in the form of a knitted, braided, or woven construct.
22 . The implant according to claim 1 , wherein the implant comprises a flexible tissue anchor, a cortical fixation device, an orthopedic suture, a bone cerclage cable, or a synthetic tendon or ligament graft.
23 . The implant according to claim 1 , wherein the implant comprises a flexible tissue anchor.